Sandra Levy
ARTICLES BY THIS AUTHOR
- 4/18/2021
FDA approves new indication for ALK's Ragwitek
Ragwitek now is indicated to treat ragweed pollen allergy in children and adolescents 5-17 years old, in addition to adults as old as 65. - 4/18/2021
New Aetna plan leverages CVS Health’s enterprise strengths
Connected Plan with CVS Health, launching in St. Louis and Southern California, includes exclusive discounts on CVS Health brand products, HealthHUB assistance and access to personalized CVS pharmacist counseling. - 4/18/2021
CVS Pharmacy, Walgreens and Walmart now selling Abbott’s at-home COVID-19 test OTC
Three leading chains are adding an OTC at-home COVID-19 test to their offerings. - 4/18/2021
NAB's Smith touts pharmacy's trusted role to Senate subcommittee
In describing insights from the National Association of Broadcasters' partnership with the Reynolds Journey Institute, NAB's Gordon Smith highlighted findings that underscored local pharmacies as trusted community messengers. - 4/15/2021
FDA clears Opdivo as first-line gastric cancer treatment
Opdivo is the first FDA-approved immunotherapy for the first-line treatment of gastric cancer. - 4/15/2021
Nexus intros generic Quelicin
Generic Quelicin is a sterile, nonpyrogenic solution that is used as an ultra-short-acting, depolarizing, skeletal muscle relaxant. - 4/15/2021
FDA clears Nextstellis from Mayne, Mithra
Nextstellis is the first and only contraceptive pill containing estetrol, a native estrogen, which is produced from a plant source. It is also the first new estrogen to hit the U.S. market in more than 50 years, the company said. - 4/14/2021
NACDS lauds CMS administrator, HHS deputy secretary nominations
The National Association of Chain Drug Stores is seeking collaboration on pandemic issues and beyond as Health and Human Services’ and Centers for Medicare and Medicaid Services’ nominees face the Senate Finance Committee. - 4/14/2021
NCPA survey highlights how independents are vaccinating underserved groups
Almost half of the respondents in a survey conducted by the National Community Pharmacists Association said they were serving populations with a significant minority population, and nearly 80% operate in places with fewer than 50,000 people. - 4/14/2021
Lannett submits ANDA for generic Advair Diskus
Advair Diskus has a market value of approximately $3 billion for the 12 months ended February 2021, although actual generic market values are expected to be lower.
